ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, regarding the progression of the disease it has been demonstrated a critical role for Erk1/2 signaling pathway in the blast crisis of CML through the suppression of the normal myeloid differentiation to neutrophil in a Bcr/Abl dose dependent fashion [51].